Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
11,323 total articles
Blue Bird (BLBD) is a market leader in school buses trading at roughly $65 with a market cap near $2.06B, double-digit free cash flow and a mid-teens P/E. For traders willing to buy a resilient industrial with low leverage and clear catalysts, a controlled long with a mid-term horizon looks attractive.
Reddit shares have pulled back sharply into an oversold technical and sentiment state despite accelerating revenue, healthy margins and strong free cash flow. This trade idea lays out a tactical long with an exact entry at $146.79, a stop at $132.11 and a primary target of $185.00 over a swing timeframe, plus paths for shorter and longer horizons.
Lamb Weston (LW) looks like a constructive risk-reward at current levels. The stock is down from its 52-week high but still generates strong free cash flow, pays a healthy dividend, and has valuation metrics that leave room for rerating if operational execution improves. Recent market chatter about shareholder activism and reports of insider buying…
Century Aluminum (CENX) is in the early innings of a potentially transformative earnings cycle fueled by near-term aluminum tightness, a landmark U.S. smelter partnership, and solid profitability metrics. This is a swing trade: entry $58.50, target $68.50, stop $53.00, with a mid-term horizon (45 trading days).
Archer-Daniels-Midland (ADM) is a pragmatic buy here. The stock trades near $77.61 after pulling back from a recent $83.10 52-week high, while the business still generates roughly $4.8B of free cash flow and yields ~2.6%. With commodity-led tailwinds for feed and ingredient demand and renewed investor focus on sustainability and nutrition, ADM look…
Amazon is trading near $265 with a $2.85T market cap, attractive growth optionality from AWS AI infrastructure and steady retail cash flow. Valuation (P/E ~31, P/S ~3.8) looks reasonable against long-term growth and profitability (ROE ~20.6%). We lay out an actionable long trade with entry, stop and target, plus catalysts and risk controls.
Cal-Maine (CALM) trades at a single-digit P/E, generates strong free cash flow and is using M&A to densify its specialty and prepared-foods footprint. Recent quarter showed steep revenue declines from normalized high prices, but profitability, balance-sheet strength and product-mix shifts create a high-conviction, mid-term swing trade: buy into wea…
Post Holdings trades below $100 with $516.8M in free cash flow and valuation multiples that suggest upside if management returns capital via buybacks. Balance sheet leverage and integration risk are real, but the math supports a buy-the-dip trade for long-term oriented investors willing to tolerate volatility.
A&W Food Services of Canada offers a yield-supported entry for patient traders. The company's franchise-heavy model and steady cash return to shareholders provide a floor under the price. This trade targets a mid-term rebound while keeping risk tight with a clear stop.
Wave Life Sciences looks cheap relative to its clinical optionality. With a reported NDA filing for its DMD program (WVE-N531) and fresh progress in alpha-1 antitrypsin deficiency (AATD), the risk/reward profile favors buying the stock at current levels. Strong cash resources, a recently upsized $350M offering and undersold technicals support a lon…
Reddit is investing aggressively in its content feed and monetization tools. Recent user-growth and margin trends show the company is scaling profitably; at $146.94 the market is pricing in a lot of AI-related downside. This trade targets a mid-term rebound as feed investments translate into higher engagement and ad yield.
YETI's premium outdoor brand, improving international traction and strong free cash flow justify a mid-term long trade. The business shows healthy margins, conservative leverage and an active marketing cadence that supports top-line resilience. Enter near $44.34, target $51.00, stop $40.00 for a mid-term (45 trading days) trade.
Hasbro's core franchises - led by Magic: The Gathering and licensing income - are driving revenue upside and healthy free cash flow. The stock pulled back after a recent momentum run; we upgrade to a tactical long based on Q1 upside, solid FCF, and attractive risk/reward into $105 while respecting leverage and operational risks.
Oklo (OKLO) is a pre-commercial advanced fission company that could become a preferred power supplier for hyperscalers and colocation providers as AI data centers struggle to secure steady, low-carbon, high-density electricity. The stock already prices in success; execution and capital discipline matter. I recommend a buy with a clear entry, stop, …
ImmunityBio (IBRX) just saw the FDA accept an expanded-use sBLA for ANKTIVA + BCG in BCG-unresponsive NMIBC with a PDUFA of 01/06/2027. The stock is trading at roughly $8.20 and a market cap near $8.6B. Positive approval odds and superior trial outcomes relative to incumbents argue for a directional long; material legal risk and high short interest…
IQVIA is a market leader in clinical data, analytics and trial execution. Recent market noise and a pullback from the January highs have left the stock trading at ~21x EPS and a $28B market cap while AI-enabled trial software markets are expanding at 20-30%+ CAGRs. We see a mid-term swing trade with defined risk that captures re-rating potential as…
Root's telematics-driven underwriting and sustained margin gains justify a tactical long. The stock trades at a modest market cap with improving ROE, healthy liquidity and compressed EV/sales multiples. I favor a mid-term trade to capture continued margin expansion while respecting near-term top-line headwinds and volatility from active short inter…
<p>Silicom (SILC) has the technical fingerprints of a breakout and a compact market structure that can amplify follow-through if the rumored large order materializes. With a market cap near $244M, a float of roughly 5.4M shares and elevated short/swing activity in mid-May, this is a tactical long for traders who can tolerate volatility.</p><p>This …
The market is pricing The Trade Desk like growth has permanently decelerated. That view neglects the company’s durable demand for programmatic, strong free cash flow generation ($842M last reported) and growing role in identity and TV monetization. At $20.80, the stock offers asymmetric upside if ad budgets normalize and platform spending drives hi…
Azure growing ~40% is a powerful revenue engine, but Microsoft is simultaneously ramping AI-specific capex and GPU purchases that compress margins. I think the net is still positive over a position horizon if Azure continues accelerating and AI monetization follows, but risks on cost and execution mean this is a medium-risk position trade with defi…
Nike is trading near its 52-week low after a sell-off that reflects weaker consumer demand and China pressures. With a market cap of ~$63.7B, a 3.8% yield and free cash flow of $1.05B, the stock looks like a tactical long for traders willing to accept medium risk. Entry at $43.05, stop at $40.50, target $52.00 over a mid-term horizon (45 trading da…
<p>Archer is transitioning from a prototype play into a commercial aircraft and mobility services company. With a market cap of about $4.53B and an enterprise value near $3.65B, the stock is pricing in high execution risk but also leaves room for a re-rate if certification, production and early service launches proceed. This idea upgrades Archer to…
Mitek (MITK) is trading around $14.19 with a market cap near $640M. The stock looks expensive on P/E (~39-41x) but the business generates healthy free cash flow ($44.5M) and carries modest leverage (debt/equity ~0.21). This trade idea argues for a tactical long into patient upside toward the $16.50 area while protecting capital with a $12.80 stop.
Resideo is a capital-light distributor and products business that has been pressured by negative free cash flow and margin compression. Recent operational steps and an improving ADI distribution backdrop set the stage for a recovery in 2H 2026. We upgrade to a buy and lay out an actionable long trade with defined entry, target and stop.
BillionToOne looks poised to re-accelerate commercial traction in 2026 driven by operational improvements, tighter cost control, and clearer payer pathways. This trade idea lays out a long entry, stop, and target with a 180-trading-day horizon while flagging dilution and regulatory risk as the primary threats to the thesis.
